Why Staying on Medication Is Harder with Dual Diagnosis
A Swedish study of over 43,000 adults with ADHD found those with substance use disorder are nearly twice as likely to stop taking prescribed medication. The research, published May 21, 2026, in BMJ Mental Health, tracked patients between 2007 and 2023 to assess treatment continuity.
Wellness insights
Breaking Free from Workplace Gridlock
Pillars of a Meaningful Life
The Hidden Struggle of Mothers Caring for Children With Disabilities
Freud's Ideas Clash with Modern Brain ScienceThe data showed 44% of ADHD patients with substance use disorder discontinued medication within three years, compared to 24% of those without SUD. Researchers adjusted for age, sex, psychiatric history, and socioeconomic factors. The study highlights how substance use complicates long-term ADHD treatment and suggests the need for integrated care models.
Patients facing both ADHD and substance use disorder often struggle with adherence due to overlapping symptoms and behavioral patterns. Impulsivity and difficulty with self-regulation—common in ADHD—can worsen substance misuse, creating a cycle that disrupts treatment routines. The study authors note that stimulant medications, commonly prescribed for ADHD, may be misused or diverted in patients with SUD, raising concerns among clinicians.
Could Integrated Care Improve Outcomes?
Healthcare providers may hesitate to prescribe stimulants to patients with active substance use, fearing dependency or worsening addiction. This caution, while well-intentioned, can lead to undertreatment of ADHD symptoms, further reducing motivation to stay on medication. The research team emphasized that improved monitoring and non-stimulant alternatives could help maintain treatment in this high-risk group.
Treating ADHD and substance use disorder in isolation may explain the high dropout rate, experts suggest. Coordinated care that addresses both conditions simultaneously could improve medication adherence and long-term outcomes. The study found that patients receiving concurrent psychiatric and addiction support were more likely to remain in treatment.
Dr. Lena Moller, lead researcher, stated, „Our findings don’t mean medication should be withheld. Instead, they show the need for tailored support.” She added that structured follow-ups and patient education could reduce discontinuation risks.
Frequently Asked Questions
What was the main finding of the study? Adults with ADHD and substance use disorder were almost twice as likely to stop medication compared to those with ADHD alone. The dropout rate was 44% within three years for the dual-diagnosis group.
Does this mean ADHD medication worsens addiction? No. The study does not suggest medication causes or worsens substance use. Instead, it shows that patients with both conditions face greater challenges in sticking to treatment plans.
Could better care reduce medication dropout? Yes. The study suggests integrated treatment for both ADHD and substance use, along with regular check-ins, could help patients stay on medication and improve overall outcomes.
